Ozempic and Alzheimer's, the war on alcohol taxes, UnitedHealth report

Plus: State ballot initiatives on psychedelics and medically-assisted suicide

October 24, 2024 Check out STAT+

Sponsored By

Justin Sullivan/Getty Images The war against alcohol taxes Today's health news includes the war against alcohol taxes, Kamala Harris' health policy priorities, retinal implants, and more. By Theresa Gaffney How a Kamala Harris presidency would change health care, from drug pricing to abortion New Medicare benefit for home care, drug pricing changes, surprise billing protections, and codifying abortion access all require action from lawmakers. By Rachel Cohrs Zhang STAT+ | Ozempic linked to lower risk of Alzheimer's diagnosis in observational study In the observational study, the drug was tied with a 40% to 70% lower risk of an Alzheimer's diagnosis over three years compared with other diabetes drugs. By Elaine Chen Adobe STAT+ | UnitedHealth collected billions in questionable Medicare payments, federal watchdog finds Insurers used home visits and medical chart reviews to diagnose Medicare Advantage patients with conditions for which they received no follow-up care, a federal watchdog found.    By Casey Ross, Tara Bannow, Lizzy Lawrence, and Bob Herman The key ballot measures and races to watch that could reshape health care Ten states have ballot initiatives on abortion this fall. Others include Medicaid work requirements, medically assisted suicide, and recreational drugs. By Sarah Owermohle Opinion: 'Do no harm' is hurting 400 million long Covid patients worldwide Waiting for gold-standard clinical trial data means that people with long Covid are suffering needlessly. Doctors should help with off-label drugs. By Julia Moore Vogel and Charlie McCone Matt Rourke/AP Opinion: Trump's and Harris' vitriolic attacks on each other's mental health are shameful Trump calls Harris mentally impaired. Harris calls Trump unstable and unfit. Obscured by the rhetoric is America's ongoing crisis in mental health. By Lawrence K. Altman STAT+ | Q&A: At Flagship's London outpost, an executive sees scientific potential ready to 'unlock' The high-profile venture firm Flagship Pioneering opened its U.K. office last year and is interested in finding ways to harness more talent, and data. By Andrew Joseph

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser